Search Results for "vaccine, MMR"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vaccine, MMR. Results 11 to 13 of 13 total matches.
See also: MMR II, MMRV, ProQuad

Expanded Table: Some Vaccines for Adults (online only)

   
The Medical Letter on Drugs and Therapeutics • Oct 17, 2022  (Issue 1661)
during or after 1980 without evidence of immunity (documentation of vaccination, laboratory evidence ...
Med Lett Drugs Ther. 2022 Oct 17;64(1661):e170-3 |  Show IntroductionHide Introduction

In Brief: Measles Outbreak

   
The Medical Letter on Drugs and Therapeutics • Jun 02, 2008  (Issue 1287)
history of clinical measles, no documentation of vaccination, and no laboratory evidence of immunity ...
The US Centers for Disease Control and Prevention (CDC) has reported that measles outbreaks have occurred in New York City, California and Arizona in 2008, and additional cases have been confirmed in Michigan, Wisconsin, Hawaii, New York State, Pennsylvania, Illinois and Virginia (CDC Health Advisory, May 1, 2008). To date, 63 of the 64 infected patients were unvaccinated, and 54 of the cases were associated with importation of the disease. Both measles infection and vaccination (2 doses at least 28 days apart, with the first dose no earlier than 12 months of age) generally provide lifelong...
Med Lett Drugs Ther. 2008 Jun 2;50(1287):41 |  Show IntroductionHide Introduction

VariZIG for Prophylaxis After Exposure to Varicella

   
The Medical Letter on Drugs and Therapeutics • Aug 14, 2006  (Issue 1241)
. Vaccination with live vaccines, such as measles, mumps and rubella (MMR), should be delayed for at least 3 ...
The US manufacturer of varicella zoster immune globulin (VZIG; Massachusetts Public Health Biologic Laboratories, Boston, MA) recently discontinued its production. A Canadian formulation, VariZIG (Varicella Zoster Immune Globulin [Human] - Cangene Corporation, Winnipeg) is now available in the US under an investigational new drug application expanded access protocol.
Med Lett Drugs Ther. 2006 Aug 14;48(1241):69-70 |  Show IntroductionHide Introduction